|
Volumn 36, Issue 6, 2008, Pages 295-299
|
Opportunistic fungal lung infections
a a |
Author keywords
aspergillosis; blastomycosis; candidiasis; coccidioidomycosis; cryptococcosis; fungal lung infections; histoplasmosis; paracoccidioidomycosis; pneumocystis; zygomycosis
|
Indexed keywords
AMPHOTERICIN B;
ANIDULAFUNGIN;
ANTIFUNGAL AGENT;
ATOVAQUONE;
CASPOFUNGIN;
CLINDAMYCIN;
CORTICOSTEROID;
COTRIMOXAZOLE;
ECHINOCANDIN;
FLUCONAZOLE;
ITRACONAZOLE;
KETOCONAZOLE;
PENTAMIDINE;
POLYENE;
POSACONAZOLE;
PRIMAQUINE;
PYRROLE DERIVATIVE;
STEROID;
VORICONAZOLE;
ASPERGILLOSIS;
BLASTOMYCOSIS;
CANDIDIASIS;
CLINICAL FEATURE;
COCCIDIOIDOMYCOSIS;
CRYPTOCOCCOSIS;
DRUG EFFICACY;
DRUG MEGADOSE;
HISTOPLASMOSIS;
HUMAN;
IMMUNE DEFICIENCY;
IMMUNOCOMPETENCE;
LUNG ASPERGILLOSIS;
LUNG MYCOSIS;
MUCORMYCOSIS;
NONHUMAN;
OPPORTUNISTIC INFECTION;
PNEUMOCYSTIS PNEUMONIA;
PRIORITY JOURNAL;
REVIEW;
RISK FACTOR;
SOUTH AMERICAN BLASTOMYCOSIS;
|
EID: 44149108004
PISSN: 13573039
EISSN: None
Source Type: Journal
DOI: 10.1016/j.mpmed.2008.03.010 Document Type: Review |
Times cited : (4)
|
References (10)
|